These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 15610315)

  • 1. Infrequency of colonization with Oxalobacter formigenes in inflammatory bowel disease: possible role in renal stone formation.
    Kumar R; Ghoshal UC; Singh G; Mittal RD
    J Gastroenterol Hepatol; 2004 Dec; 19(12):1403-9. PubMed ID: 15610315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intestinal colonization with Oxalobacter formigenes and its relation to urinary oxalate excretion in pediatric patients with idiopathic calcium urolithiasis.
    Sikora P; Niedźwiadek J; Mazur E; Paluch-Oleś J; Zajaczkowska M; Kozioł-Montewka M
    Arch Med Res; 2009 Jul; 40(5):369-73. PubMed ID: 19766900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absorptive hyperoxaluria leads to an increased risk for urolithiasis or nephrocalcinosis in cystic fibrosis.
    Hoppe B; von Unruh GE; Blank G; Rietschel E; Sidhu H; Laube N; Hesse A
    Am J Kidney Dis; 2005 Sep; 46(3):440-5. PubMed ID: 16129205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intestinal Oxalobacter formigenes colonization in calcium oxalate stone formers and its relation to urinary oxalate.
    Troxel SA; Sidhu H; Kaul P; Low RK
    J Endourol; 2003 Apr; 17(3):173-6. PubMed ID: 12803990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct correlation between hyperoxaluria/oxalate stone disease and the absence of the gastrointestinal tract-dwelling bacterium Oxalobacter formigenes: possible prevention by gut recolonization or enzyme replacement therapy.
    Sidhu H; Schmidt ME; Cornelius JG; Thamilselvan S; Khan SR; Hesse A; Peck AB
    J Am Soc Nephrol; 1999 Nov; 10 Suppl 14():S334-40. PubMed ID: 10541258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A critical analysis of the role of gut Oxalobacter formigenes in oxalate stone disease.
    Siva S; Barrack ER; Reddy GP; Thamilselvan V; Thamilselvan S; Menon M; Bhandari M
    BJU Int; 2009 Jan; 103(1):18-21. PubMed ID: 19021605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperoxaluria, hypocitraturia, hypomagnesiuria, and lack of intestinal colonization by Oxalobacter formigenes in a cervical spinal cord injury patient with suprapubic cystostomy, short bowel, and nephrolithiasis.
    Vaidyanathan S; von Unruh GE; Watson ID; Laube N; Willets S; Soni BL
    ScientificWorldJournal; 2006 Apr; 6():2403-10. PubMed ID: 17619709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stone composition, metabolic profile and the presence of the gut-inhabiting bacterium Oxalobacter formigenes as risk factors for renal stone formation.
    Mittal RD; Kumar R; Mittal B; Prasad R; Bhandari M
    Med Princ Pract; 2003; 12(4):208-13. PubMed ID: 12966191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of Oxalobacter formigenes to reduce urinary oxalate in primary hyperoxaluria.
    Hoppe B; Groothoff JW; Hulton SA; Cochat P; Niaudet P; Kemper MJ; Deschênes G; Unwin R; Milliner D
    Nephrol Dial Transplant; 2011 Nov; 26(11):3609-15. PubMed ID: 21460356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal stone formation in patients with inflammatory bowel disease.
    Caudarella R; Rizzoli E; Pironi L; Malavolta N; Martelli G; Poggioli G; Gozzetti G; Miglioli M
    Scanning Microsc; 1993 Mar; 7(1):371-9; discussion 379-80. PubMed ID: 8316806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of antibiotics on Oxalobacter formigenes colonization of human gastrointestinal tract.
    Mittal RD; Kumar R; Bid HK; Mittal B
    J Endourol; 2005; 19(1):102-6. PubMed ID: 15735393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of Oxalobacter formigenes in calcium oxalate stone disease: a study from North India.
    Kumar R; Mukherjee M; Bhandari M; Kumar A; Sidhu H; Mittal RD
    Eur Urol; 2002 Mar; 41(3):318-22. PubMed ID: 12180235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of intestinal oxalate-degrading bacteria with recurrent calcium kidney stone formation and hyperoxaluria: a case-control study.
    Tavasoli S; Alebouyeh M; Naji M; Shakiba Majd G; Shabani Nashtaei M; Broumandnia N; Basiri A
    BJU Int; 2020 Jan; 125(1):133-143. PubMed ID: 31145528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of Oxalobacter formigenes colonization in calcium oxalate stone disease.
    Siener R; Bangen U; Sidhu H; Hönow R; von Unruh G; Hesse A
    Kidney Int; 2013 Jun; 83(6):1144-9. PubMed ID: 23536130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxalobacter colonization in the morbidly obese and correlation with urinary stone risk.
    Duffey BG; Miyaoka R; Holmes R; Assimos D; Hinck B; Korman E; Kieley F; Ikramuddin S; Kellogg T; Moeding A; Monga M
    Urology; 2011 Sep; 78(3):531-4. PubMed ID: 21529902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative analysis of colonization with real-time PCR to identify the role of Oxalobacter formigenes in calcium oxalate urolithiasis.
    Batislam E; Yilmaz E; Yuvanc E; Kisa O; Kisa U
    Urol Res; 2012 Oct; 40(5):455-60. PubMed ID: 22215293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variability of Oxalobacter formigenes and oxalate in stool samples.
    Prokopovich S; Knight J; Assimos DG; Holmes RP
    J Urol; 2007 Nov; 178(5):2186-90. PubMed ID: 17870112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absence of Oxalobacter formigenes in cystic fibrosis patients: a risk factor for hyperoxaluria.
    Sidhu H; Hoppe B; Hesse A; Tenbrock K; Brömme S; Rietschel E; Peck AB
    Lancet; 1998 Sep; 352(9133):1026-9. PubMed ID: 9759746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lithogenic risk factors for renal stones in patients with Crohn's disease.
    Buño Soto A; Torres Jiménez R; Olveira A; Fernández-Blanco Herraiz I; Montero García A; Mateos Antón F
    Arch Esp Urol; 2001 Apr; 54(3):282-92. PubMed ID: 11432047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary excretion of N-methylhistamine as a marker of disease activity in inflammatory bowel disease.
    Winterkamp S; Weidenhiller M; Otte P; Stolper J; Schwab D; Hahn EG; Raithel M
    Am J Gastroenterol; 2002 Dec; 97(12):3071-7. PubMed ID: 12492192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.